Shanghai Kai Kai Industry Company Limited

SHSE:900943 Stock Report

Market Cap: US$366.8m

Shanghai Kai Kai Industry Past Earnings Performance

Past criteria checks 4/6

Shanghai Kai Kai Industry has been growing earnings at an average annual rate of 25.8%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 4.2% per year. Shanghai Kai Kai Industry's return on equity is 10.4%, and it has net margins of 5.1%.

Key information

25.8%

Earnings growth rate

25.2%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate4.2%
Return on equity10.4%
Net Margin5.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Shanghai Kai Kai Industry makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SHSE:900943 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,055541540
30 Jun 241,024531550
31 Mar 24960531690
31 Dec 23925391690
30 Sep 23813261880
30 Jun 23748281890
31 Mar 23915411960
31 Dec 22894401960
30 Sep 22879481600
30 Jun 22871451680
31 Mar 22657291430
31 Dec 21670221600
30 Sep 21661151540
30 Jun 21704161490
31 Mar 21743131550
31 Dec 20762141470
30 Sep 20818131530
30 Jun 20823141660
31 Mar 20825171700
31 Dec 19870221670
30 Sep 19875231930
30 Jun 19875251760
31 Mar 19887341710
31 Dec 18878351770
30 Sep 18889451420
30 Jun 18937441610
31 Mar 18947411400
31 Dec 17962391430
30 Sep 17961271690
30 Jun 17927261560
31 Mar 17913231680
31 Dec 16906211660
30 Sep 16891161650
30 Jun 16890211700
31 Mar 16887201680
31 Dec 15881201630
30 Sep 15884101480
30 Jun 1587751440
31 Mar 1589011500
31 Dec 14883361460
30 Sep 14893551300
30 Jun 14885551390
31 Mar 14876571400
31 Dec 13859251350

Quality Earnings: 900943 has a large one-off gain of CN¥76.5M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 900943's current net profit margins (5.1%) are higher than last year (3.2%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 900943's earnings have grown significantly by 25.8% per year over the past 5 years.

Accelerating Growth: 900943's earnings growth over the past year (105.5%) exceeds its 5-year average (25.8% per year).

Earnings vs Industry: 900943 earnings growth over the past year (105.5%) exceeded the Pharmaceuticals industry -2.5%.

Return on Equity

High ROE: 900943's Return on Equity (10.4%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 01:23
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanghai Kai Kai Industry Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution